Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways

Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways

Radiotherapy is one of the most common treatment options for local or regional advanced prostate cancer (PCa). Importantly, PCa is prone to radioresistance and often develops into malignancies after long-term radiotherapy. Antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, possesse...

Full description

Bibliographic Details
Main Authors: Yu-An Chen, David T. W. Tzeng, Yi-Ping Huang, Chun-Jung Lin, U-Ging Lo, Chia-Lin Wu, Ho Lin, Jer-Tsong Hsieh, Chih-Hsin Tang, Chih-Ho Lai
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Cancers
Subjects:
prostate cancer
radiotherapy
radioresistance
antrocin
Online Access:http://www.mdpi.com/2072-6694/11/1/34

Similar Items

Similar Items